Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies. | Blood Cancer J | 2022 | 35654786 | PubTator, text mining | PubMed |
| Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases. | Front Pharmacol | 2022 | 35652048 | PubTator, text mining | PubMed |
| High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors. | Front Oncol | 2022 | 35646715 | PubTator, text mining | PubMed |
| miR-451a targeting IL-6R activates JAK2/STAT3 pathway, thus regulates proliferation and apoptosis of multiple myeloma cells. | J Musculoskelet Neuronal Interact | 2022 | 35642704 | PubTator, text mining | PubMed |
| Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials. | Cancer Commun (Lond) | 2022 | 35642676 | PubTator, text mining | PubMed |
| Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension. | Biochem Pharmacol | 2022 | 35640713 | PubTator, text mining | PubMed |
| Uncovering Robust Delactoylase and Depyruvoylase Activities of HDAC Isoforms. | ACS Chem Biol | 2022 | 35639992 | PubTator, text mining | PubMed |
| Identification of Naturally Processed Epitope Region Using Artificial APC Expressing a Single HLA Class I Allotype and mRNA of HCMV pp65 Antigen Fragments. | Vaccines (Basel) | 2022 | 35632543 | PubTator, text mining | PubMed |
| A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs). | Pharmaceuticals (Basel) | 2022 | 35631362 | PubTator, text mining | PubMed |
| Design, Synthesis, Bioactivity Evaluation, Crystal Structures, and In Silico Studies of New α-Amino Amide Derivatives as Potential Histone Deacetylase 6 Inhibitors. | Molecules | 2022 | 35630812 | PubTator, text mining | PubMed |
| Sex Differences in Psychostimulant Abuse: Implications for Estrogen Receptors and Histone Deacetylases. | Genes (Basel) | 2022 | 35627277 | PubTator, text mining | PubMed |
| A Novel de Novo Variant in 5' UTR of the NIPBL Associated with Cornelia de Lange Syndrome. | Genes (Basel) | 2022 | 35627125 | PubTator, text mining | PubMed |
| Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option. | Cells | 2022 | 35626663 | PubTator, text mining | PubMed |
| Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go? | Cancers (Basel) | 2022 | 35626024 | PubTator, text mining | PubMed |
| The Role of the Metabolism of Zinc and Manganese Ions in Human Cancerogenesis. | Biomedicines | 2022 | 35625809 | PubTator, text mining | PubMed |
| Transcription Pause and Escape in Neurodevelopmental Disorders. | Front Neurosci | 2022 | 35615272 | PubTator, text mining | PubMed |
| Effects of valproic acid on SOCS-1, SOCS-2, SOCS-3, SOCS-5, SOCS6, and SOCS-7 gene expression and cell growth inhibition in colon carcinoma. | Gastroenterol Hepatol Bed Bench | 2022 | 35611249 | PubTator, text mining | PubMed |
| Crosstalk of Histone and RNA Modifications Identified a Stromal-Activated Subtype with Poor Survival and Resistance to Immunotherapy in Gastric Cancer. | Front Pharmacol | 2022 | 35600848 | PubTator, text mining | PubMed |
| RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality? | Front Oncol | 2022 | 35600358 | PubTator, text mining | PubMed |
| The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers. | Integr Cancer Ther | 2022 | 35593403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=36